trt; hypogonadism; fda; healthcare

https://www.urologytimes.com/view/mohit-khera-md-recaps-key-takeaways-from-fda-panel-on-trt-for-men Mohit Khera, MD, MBA, MPH, recaps key takeaways from an FDA expert panel discussion on testosterone replacement therapy for men. In a recent interview with Urology Times®, Mohit Khera, MD, MBA...

* This landmark event marks a pivotal moment in the advancement of men’s health and represents a major milestone for Marius, which has worked for years to elevate the scientific conversation surrounding testosterone and address longstanding misconceptions. * Shah will join an esteemed group of...

Recognizing the True Value of Testosterone Therapy in Health Care (2022) Abraham Morgentaler, * Abdulmaged Traish, Rajat S. Barua, Paresh Dandona, Sandeep Dhindsa, Mohit Khera, and Farid Saad Abstract There has been little recognition within the medical community of the health impact of...